Protagen, Mikrogen Team on Array-based Dx | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Protagen today said that it is working with German diagnostics firm Mikrogen on jointly developing infectious disease diagnostics based on Protagen's UNIarray platform.

The firms have conducted a feasibility study for identifying typical autoantibody signatures in infectious diseases that may be useful for diagnostic tests.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.